Seroatlas · Human Serome Atlas

KCNJ2

Inward rectifier potassium channel 2

Also known as: IRK1, KCNJ2_HUMAN, Kir2.1, LQT7

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P63252
Gene
KCNJ2
Ensembl
ENSG00000123700
Chromosome
17
Canonical length
427 aa
Protein class
Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels
Quaternary structure
Homotetramer

OverviewNCBI Gene

Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Mutations in this gene have been associated with Andersen syndrome, which is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

427 residues, UniProt reviewed canonical sequence.

>P63252|KCNJ2
     1  MGSVRTNRYS IVSSEEDGMK LATMAVANGF GNGKSKVHTR QQCRSRFVKK DGHCNVQFIN
    61  VGEKGQRYLA DIFTTCVDIR WRWMLVIFCL AFVLSWLFFG CVFWLIALLH GDLDASKEGK
   121  ACVSEVNSFT AAFLFSIETQ TTIGYGFRCV TDECPIAVFM VVFQSIVGCI IDAFIIGAVM
   181  AKMAKPKKRN ETLVFSHNAV IAMRDGKLCL MWRVGNLRKS HLVEAHVRAQ LLKSRITSEG
   241  EYIPLDQIDI NVGFDSGIDR IFLVSPITIV HEIDEDSPLY DLSKQDIDNA DFEIVVILEG
   301  MVEATAMTTQ CRSSYLANEI LWGHRYEPVL FEEKHYYKVD YSRFHKTYEV PNTPLCSARD
   361  LAEKKYILSN ANSFCYENEV ALTSKEEDDS ENGVPESTST DTPPDIDLHN QASVPLEPRP
   421  LRRESEI

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against KCNJ2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
2
Mean surface accessibility (rSASA)
0.39
Highest tissue expression
34 nTPM

Expression across tissuesHPA

Tissue

  • parathyroid gland: 34 nTPM
  • heart muscle: 9.2 nTPM
  • skeletal muscle: 9.1 nTPM
  • tongue: 7.8 nTPM
  • retina: 7.1 nTPM
  • spleen: 6.9 nTPM

Single-cell type

  • neutrophils: 313 nCPM
  • oligodendrocytes: 159 nCPM
  • retinal horizontal cells: 152 nCPM
  • cardiomyocytes: 107 nCPM
  • kupffer cells: 92 nCPM
  • myonuclei: 74 nCPM

Immune cell

  • neutrophil: 31 nTPM
  • non-classical monocyte: 7.3 nTPM
  • intermediate monocyte: 6.9 nTPM
  • eosinophil: 5.6 nTPM
  • basophil: 4.2 nTPM
  • classical monocyte: 3.5 nTPM

Brain region

  • white matter: 95 nTPM
  • basal ganglia: 48 nTPM
  • medulla oblongata: 48 nTPM
  • pons: 47 nTPM
  • midbrain: 42 nTPM
  • thalamus: 39 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about KCNJ2.

Disease | AllUniProt

Conditions KCNJ2 is implicated in, by any mechanism.

Disease | GeneticClinVar

65 pathogenic / likely-pathogenic of 680 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.62
gnomAD pLI
0.31
gnomAD missense Z
2.75
DepMap mean gene effect
-0.01
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads KCNJ2 as an antibody target. Whether an autoantibody or antibody against KCNJ2 could matter depends on whether native KCNJ2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

KCNJ2 is annotated at the cell surface, where native KCNJ2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label KCNJ2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/KCNJ2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...